Venus Remedies Secures Multiple Marketing Authorizations for Key Pharmaceuticals in Ukraine

Venus Remedies has announced the receipt of multiple Marketing Authorizations (MAs) from Ukraine (Asia CIS). We have obtained MAs for CISPLATIN 50MG/50ML and 10MG/20ML, IMIPENEM AND CILASTATIN 500MG, and MEROPENEM 500MG,1G, and 2G. These authorizations mark significant milestones in our commitment to providing highquality pharmaceutical products across the region.

Shares of Venus Remedies Limited was last trading in BSE at Rs. 389.55 as compared to the previous close of Rs. 400.05. The total number of shares traded during the day was 17308 in over 1038 trades.

The stock hit an intraday high of Rs. 418.45 and intraday low of 384.60. The net turnover during the day was Rs. 7025327.00.

Source : Equity Bulls

Keywords

VenusRemedies INE411B01019 MarketingAuthorizations Ukraine